Bormioli Pharma Ophthalmic Dosing Design


Bormioli Pharma Ophthalmic Dosing Design

Bormioli-Pharma-Ophthalmic-Dosing-Design_800x600.png Bormioli Pharma Ophthalmic Dosing Design

Bormioli Pharma Ophthalmic Dosing Design
New New Idea contest on Desall.com: Bormioli Pharma is looking for an innovative dosing system for liquid drugs dedicated to the ophthalmic sector (eye care), which allows the user to precisely control the quantity of liquid dispensed. The proposed projects should aim to develop innovative dosing systems that allow dosing specific units of measurement, thus increasing the flexibility of the product.

For more info: https://bit.ly/Bormioli-Ophthalmic-Dosing

Contest Timeline
Upload phase: 21 April 2022 – 21 July 2022 (1.59 PM UTC)
Client vote phase: from 21 July 2022
Winner announcement: approx. by the end of September 2022

Award
€5000

Eligibility Criteria
Bormioli Pharma and Desall invite you to design a dosing system for the administration of ophthalmic products, or ocular therapies, in which the drug is taken in liquid form. Deadline: July 21, 2022.

For more info: https://bit.ly/Bormioli-Ophthalmic-Dosing


Bormioli Pharma and Desall invite you to design a dosing system for the administration of ophthalmic products, or ocular therapies, in which the drug is taken in liquid form. Deadline: July 21, 2022.

Link to Registration form

Open to the public/Minimum requirements (Open to anyone that complies with the requirements)

Bormioli Pharma and Desall invite you to design a dosing system for the administration of ophthalmic products, or ocular therapies, in which the drug is taken in liquid form. Deadline: July 21, 2022.

Registration Opens
Registration Closes July 21, 2022
Deadline to Submit Project July 21, 2022
Winners announcement Date

Location of Project (if developed)

Banner, Poster, Brochure or Triptic of Competition

Bormioli-Pharma-Ophthalmic-Dosing-Design_Brief_ENG.pdf





Source link

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *